Drugs / BMS-779788
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00836602 Comparator | Feb → Jul 2009 | atherosclerosis | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-779788 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00836602 ↗ |
| Known as | BMS 788 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3360975 ↗ |
| Known as | EXEL 04286652 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3360975 ↗ |
| Known as | XL 652 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3360975 ↗ |
| Known as | XL-014 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3360975 ↗ |
| Action | Activate | “LXR-beta agonist” CHEMBL3360975 ↗ |
| Modality | Small molecule | — CHEMBL3360975 ↗ |
| Route | Oral | “Oral Solution, Oral” NCT00836602 ↗ |
| Target | NR1H2 | “LXR-beta agonist” CHEMBL3360975 ↗ |